Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)
Close on Nov 13, 2026Market cap $5.33MP/E –Yield –
Intelligent Bio Solutions profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Intelligent Bio Solutions's profit margin for the twelve months ending Sep 30, 2026 was -269.3%. For fiscal 2026 it was -294.9%, against -346.2% the year before. The highest annual figure on record is -294.9% in fiscal 2026.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -294.9% | +51.3 |
| FY2025 | Jun 30, 2025 | -346.2% | −19.8 |
| FY2024 | Jun 30, 2024 | -326.4% | +519.5 |
| FY2023 | Jun 30, 2023 | -845.9% | +1054.2 |
| FY2022 | Jun 30, 2022 | -1900.1% | −1544.7 |
| FY2021 | Jun 30, 2021 | -355.3% | +1320.9 |
| FY2020 | Jun 30, 2020 | -1676.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -191.0% | +77.3 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -341.0% | +25.1 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -269.9% | +79.1 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -298.6% | +71.7 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -268.3% | +39.6 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -366.2% | +364.8 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -349.0% | −20.9 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -370.3% | −155.6 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -307.9% | −40.2 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -731.0% | −130.9 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -328.1% | +1059.9 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -214.7% | −96.8 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -267.7% | +120.4 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -600.0% | +2508.4 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -1388.0% | −694.4 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -117.9% | +1828.2 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -388.1% | −335.1 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -3108.5% | +6013.2 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -693.6% | +7.3 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -1946.1% | −11.1 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -53.1% | +2608.3 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -9121.6% | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -701.0% | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -1935.0% | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -2661.3% | – |
See a number that looks wrong?